Zhejiang Xianju Pharmaceutical Co., Ltd. (SHE:002332)

China · Delayed Price · Currency is CNY

8.89

+0.01 (0.11%)

Oct 28, 2026, 1:15 PM CST

Market Cap	8.63B -8.9%
Revenue (ttm)	3.86B +7.6%
Net Income	465.17M +70.0%
EPS	0.47 +69.4%
Shares Out	971.25M
PE Ratio	19.04
Forward PE	18.69
Dividend	0.40 (4.50%)
Ex-Dividend Date	Sep 16, 2026

Volume	12,517,670
Open	8.52
Previous Close	8.88
Day's Range	8.52 - 8.96
52-Week Range	7.92 - 10.05
Beta	0.19
Analysts	Strong Buy
Price Target	11.35 (+27.67%)
Earnings Date	Oct 26, 2026

About SHE:002332

Zhejiang Xianju Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of steroid raw materials and preparations in China and internationally. The company offers cortical steriod, gynecology and family planning, respiratory, and dermatological drugs, as well as anaesthetic and muscle relaxants; and active pharmaceutical ingredients and intermediates. It is also involved in the provision of contract development and manufacturing organization; contract manufacturing organization; techn... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1972

Employees 3,209

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 002332

Full Company Profile

Financial Performance

In 2025, SHE:002332's revenue was 3.76 billion, a decrease of -6.04% compared to the previous year's 4.00 billion. Earnings were 449.64 million, an increase of 13.21%.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for 002332 stock is "Strong Buy." The 12-month stock price target is ¥11.35, which is an increase of 27.67% from the latest price.

Price Target

¥11.35

(27.67% upside)

Analyst Consensus: Strong Buy

Stock Forecasts